1,1-Cyclohexanediacetic Acidum Monoamide (CAM) CAS 99189-60-3 Puritas >99.0% (HPLC)

Description:

1,1-Cyclohexanediacetic Acidum Monoamide (CAM)

CAS: 99189-60-3

Puritas: >99.0% (HPLC)

Aspectus: Crystallinus Powder Alba

Medium Gabapentin (CAS: 60142-96-3)

High Quality, Commercial Production

E-Mail: alvin@ruifuchem.com

Mitte ad nos inscriptio

Product Detail

Product Tags

Descriptio:

Manufacturer Supple Gabapentin intermedia:
Gabapentin CAS 60142-96-3
1,1-Cyclohexanediaceticum Acidum (CDA) CAS 4355-11-7
Gabapentin-Lactam (CDI) CAS 64744-50-9
1,1-Cyclohexanediacetic Anhydride (CAA) CAS 1010-26-0
3,3-Pentamethylene Glutarimide (CAI) CAS 1130-32-1
1,1-Cyclohexanediacetic Acidum Monoamide (CAM) CAS 99189-60-3

Chemical Properties:

Nomen chemicum	1,1-Cyclohexanediacetic Acidum Monoamide
Synonyma	CAM;1-(Carbamoylmethyl) acidum cyclohexaneaceticum;1-(2-Amino-2-oxoethyl) acidum cyclohexaneaceticum
CAS Number	99189-60-3
CATTUS Number	RF-PI1240
Stock Status	In Stock, Productio Ascendite ad Tons
Formulae hypotheticae	C10H17NO3
M. Pondus	199.25
Brand	Ruifu Chemical

Specifications:

Item	Specifications
Aspectus	Crystallina pulveris alba
Puritas / Analysis Methodus	>99.0% (HPLC)
Liquescens punctum	144.0~148.0℃
Damnum in Siccatio	<0.50%
Residere in Ignition	<0.20%
Imine	<1.0%
Aconitum Salis	<500ppm
CDA	<1.00% (1,1-Cyclohexanediaceticum Acidum, CAS: 4355-11-7).
Totalis immunditias	<1.00%
Metalla gravis	<20ppm
Test Standard	Enterprise Standard
Consuetudinem	Medium Gabapentin (CAS: 60142-96-3)

Sarcina & Repono:

sarcina: Utrem, aluminium foil, sacculum, 25kg/cardboard Drum, vel secundum exigentiam emptoris.

Repono Condition:Repone in vasis signatis in loco frigido et sicco;A luce et humore protege.

commoda:

FAQ:

Applicatio:

1,1-Cyclohexanediacetic Acidum Monoamide (CAM) (CAS: 99189-60-3) clavis medium Gabapentin est (CAS: 60142-96-3).Gabapentin medicamentum anticonvulsans praesertim ad invasiones partiales et neuropathicum dolorem tractandas adhibetur.Medicamen primae lineae est ad curationem doloris neuropathici, quae causatur neuropathia diabetica, neuralgia postherpetica, et dolor centralis.Gabapentin usui anno 1993 primum probatus est. Praesto fuit medicamentum genericum in Civitatibus Foederatis Americae ab anno 2004. Gabapentin est structura Acidum Amino ad γ-Aminobutyricum acidum (GABA) transire destinatum ob impedimentum cerebri sanguinis.